Q&A: A Startup Scouring The Metabolome for Precision Medicine Biomarkers
Last month, Dr. Elizabeth O’Day of Waltham, MA-based precision medicine startup Olaris, Inc. was kind enough to visit DRG’s Burlington, MA office to kick off our speaker series on the future of healthcare. We caught up with her afterwards to talk about the exciting work her company is doing using machine learning to identify new biomarkers for drug responsiveness in the metabolome
Read more...